Motohiro Yamamori Selected Research

Motohiro Yamamori Research Topics

Disease

10	Esophageal Squamous Cell Carcinoma 01/2014 - 06/2007
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 08/2008
5	Colorectal Neoplasms (Colorectal Cancer) 01/2014 - 02/2009
5	Neoplasms (Cancer) 01/2013 - 02/2008
3	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2017 - 08/2011
3	Hypersensitivity (Allergy) 01/2014 - 03/2011
3	Adenocarcinoma 04/2008 - 12/2004
2	Mucositis 04/2017 - 08/2011
2	Inflammation (Inflammations) 01/2016 - 08/2007
2	Neoplasm Metastasis (Metastasis) 01/2013 - 12/2004
2	Esophageal Neoplasms (Esophageal Cancer) 07/2010 - 05/2009
1	Adenocarcinoma of Lung 01/2022
1	Stomach Neoplasms (Stomach Cancer) 11/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Anemia 01/2016
1	Stomatitis 07/2012
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2011
1	Neutropenia 02/2009
1	Anorexia 02/2009
1	Leukopenia 08/2008
1	Cheilitis 08/2008
1	Carcinoma (Carcinomatosis) 02/2008
1	Autoimmune Diseases (Autoimmune Disease) 12/2007

Drug/Important Bio-Agent (IBA)

12	Fluorouracil (Carac)FDA LinkGeneric 01/2014 - 06/2007
8	Cisplatin (Platino)FDA LinkGeneric 01/2014 - 06/2007
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 12/2004
3	Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2012
3	Troglitazone (Rezulin)FDA Link 01/2022 - 12/2011
3	Antineoplastic Agents (Antineoplastics)IBA 11/2021 - 10/2011
3	Methotrexate (Mexate)FDA LinkGeneric 04/2017 - 08/2011
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2017 - 08/2011
3	Biomarkers (Surrogate Marker)IBA 01/2014 - 05/2009
2	Telmisartan (Micardis)FDA Link 11/2021 - 01/2021
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2017 - 12/2007
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2014 - 03/2011
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2014 - 03/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013 - 07/2010
2	PlatinumIBA 10/2011 - 09/2009
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2008 - 02/2008
2	Messenger RNA (mRNA)IBA 04/2008 - 12/2004
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2022
1	TOR Serine-Threonine KinasesIBA 01/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2017
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	C-Reactive ProteinIBA 01/2016
1	Alanine Transaminase (SGPT)IBA 01/2016
1	NitrogenIBA 01/2016
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2016
1	Urea (Carbamide)FDA LinkGeneric 01/2016
1	Cytostatic AgentsIBA 07/2012
1	Zoledronic Acid (Zometa)FDA Link 05/2012
1	Mevalonic Acid (Mevalonate)IBA 05/2012
1	Thyroid Hormone Receptors beta (TR beta)IBA 01/2012
1	LigandsIBA 01/2012
1	p38 Mitogen-Activated Protein KinasesIBA 12/2011
1	Etoposide (VP 16)FDA LinkGeneric 10/2011
1	Procarbazine (Matulane)FDA Link 10/2011
1	Asparaginase (Elspar)FDA Link 10/2011
1	Teniposide (VM 26)FDA Link 10/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2011
1	Docetaxel (Taxotere)FDA Link 10/2011
1	CamptothecinIBA 07/2011
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 07/2011
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 07/2011
1	SteroidsIBA 03/2011
1	nedaplatinIBA 09/2009
1	UracilIBA 02/2009
1	Leucovorin (Folinic Acid)FDA Link 02/2009
1	Irinotecan (Camptosar)FDA LinkGeneric 02/2009
1	TegafurIBA 02/2009
1	Alkaline PhosphataseIBA 04/2008
1	Butyric Acid (Butanoic Acid)IBA 04/2008
1	CollagenIBA 02/2008
1	Prednisolone (Predate)FDA LinkGeneric 08/2007

Therapy/Procedure

10	Chemoradiotherapy 01/2014 - 06/2007
5	Drug Therapy (Chemotherapy) 01/2022 - 08/2008
5	Aftercare (After-Treatment) 01/2014 - 07/2010
3	Hematopoietic Stem Cell Transplantation 04/2017 - 08/2011
2	Therapeutics 01/2014 - 03/2011
2	Radiotherapy 05/2012 - 08/2008
1	Organ Transplantation 07/2012
1	Treatment Delay 02/2009